Investigating Disinhibitory Brain Mechanism in Tinnitus and Hearing Loss
NCT04862572
Behavior, Ear Diseases
Nottingham, United Kingdom
View Trial DetailsNCT Number: NCT00976547
Objective: To evaluate the correlation between audiometric thresholds, pitch matching (PM), minimum masking level (MML), Tinnitus Handicap Inventory (THI) and the Beck Depression Inventory (BDI) in tinnitus patients.
Subjects: 48 patients with tinnitus as the main complaint from OTOSUL, Otorrinolaringologia Sul-Fluminense, Volta Redonda, RJ, Brasil and Centro de Tratamento e Pesquisa em Zumbido, Belo Horizonte, MG, Brasil.
Method: Subjects performed tonal audiometry, Pitch Matching (PM) and Minimum Masking Level (MML) for tinnitus. They also fulfilled the Tinnitus Handicap Inventory (THI) and Beck Depression Inventory (BDI). Data was statistically compared for correlation between audiometric thresholds, psycho-acoustic measures and questionnaires.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Centro de Diagnóstico e Tratamento do Zumbido, Belo Horizonte, Minas Gerais, Brazil
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Faculdade de Medicina de Valenca
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04862572
Behavior, Ear Diseases
Nottingham, United Kingdom
View Trial DetailsNCT04262050
Behavior, Behavioral Symptoms
View Trial DetailsNCT00371436
Ear Diseases, Hearing Disorders
Tampa, Florida, United States
View Trial DetailsNCT01229709
Anxiety, Anxiety Disorders
San Francisco, California, United States
View Trial Details